Nonproteinuric Diabetic Nephropathy. When Diabetics Don't Read the Textbook.

Medical Clinics of North America

Volumn 97, Issue 1, 2013, Pages 53-58

  Dwyer, Jamie P ^a   Lewis, Julia B ^a  

^a VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Diabetic nephropathy; Nonproteinuric; Normoalbuminuria

Indexed keywords

CREATININE; SULODEXIDE;

ACUTE KIDNEY FAILURE; ALBUMINURIA; CREATININE BLOOD LEVEL; CROSS-SECTIONAL STUDY; DIABETIC NEPHROPATHY; GLOMERULUS FILTRATION RATE; GLYCEMIC CONTROL; HUMAN; KIDNEY FAILURE; KIDNEY FUNCTION; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PRIORITY JOURNAL; PROTEINURIA; REVIEW;

ANIMALS; CLINICAL TRIALS AS TOPIC; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; DIABETIC NEPHROPATHIES; HUMANS; KIDNEY; KIDNEY FUNCTION TESTS; MODELS, ANIMAL; PROTEINURIA; RATS; RENIN-ANGIOTENSIN SYSTEM;

EID: 84871819492     PISSN: 00257125     EISSN: 15579859     Source Type: Journal    
DOI: 10.1016/j.mcna.2012.10.006     Document Type: Review

References (24)

1. Dwyer J.P., Lewis J.B. Clinical aspects of diabetic nephropathy. Schrier's diseases of the kidney 2013, Wolters Kluwer Health/Lippincott Williams & Wilkins, Philadelphia, 1659-75. 9th edition. R.W. Schrier, T.M. Coffman, R.J. Falk (Eds.).
2. Kussman M.J., Goldstein H., Gleason R.E. The clinical course of diabetic nephropathy. JAMA 1976, 236(16):1861-1863.
3. Adler A.I., Stevens R.J., Manley S.E., et al. Development and progression of nephropathy in type 2 diabetes: the United Kingdom Prospective Diabetes Study (UKPDS 64). Kidney Int 2003, 63(1):225-232.
4. Lewis E.J., Hunsicker L.G., Bain R.P., et al. The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. The Collaborative Study Group. N Engl J Med 1993, 329(20):1456-1462.
5. Lewis E.J., Hunsicker L.G., Clarke W.R., et al. Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes. N Engl J Med 2001, 345(12):851-860.
6. Brenner B.M., Cooper M.E., de Zeeuw D., et al. Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy. N Engl J Med 2001, 345(12):861-869.
7. Parving H.H., Lehnert H., Brochner-Mortensen J., et al. The effect of irbesartan on the development of diabetic nephropathy in patients with type 2 diabetes. N Engl J Med 2001, 345(12):870-878.
8. Haller H., Ito S., Izzo J.L., et al. Olmesartan for the delay or prevention of microalbuminuria in type 2 diabetes. N Engl J Med 2011, 364(10):907-917.
9. Weksler-Zangen S., Yagil C., Zangen D.H., et al. The newly inbred cohen diabetic rat: a nonobese normolipidemic genetic model of diet-induced type 2 diabetes expressing sex differences. Diabetes 2001, 50(11):2521-2529.
10. Yagil C., Barak A., Ben-Dor D., et al. Nonproteinuric diabetes-associated nephropathy in the Cohen rat model of type 2 diabetes. Diabetes 2005, 54(5):1487-1496.
11. Lane P.H., Steffes M.W., Mauer S.M. Glomerular structure in IDDM women with low glomerular filtration rate and normal urinary albumin excretion. Diabetes 1992, 41(5):581-586.
12. Rigalleau V., Lasseur C., Raffaitin C., et al. Normoalbuminuric renal-insufficient diabetic patients: a lower-risk group. Diabetes Care 2007, 30(8):2034-2039.
13. Atkins R.C., Briganti E.M., Lewis J.B., et al. Proteinuria reduction and progression to renal failure in patients with type 2 diabetes mellitus and overt nephropathy. Am J Kidney Dis 2005, 45(2):281-287.
14. de Zeeuw D., Remuzzi G., Parving H.H., et al. Albuminuria, a therapeutic target for cardiovascular protection in type 2 diabetic patients with nephropathy. Circulation 2004, 110(8):921-927.
15. de Zeeuw D., Remuzzi G., Parving H.H., et al. Proteinuria, a target for renoprotection in patients with type 2 diabetic nephropathy: lessons from RENAAL. Kidney Int 2004, 65(6):2309-2320.
16. Retnakaran R., Cull C.A., Thorne K.I., et al. Risk factors for renal dysfunction in type 2 diabetes: U.K. Prospective Diabetes Study 74. Diabetes 2006, 55(6):1832-1839.
17. Garg A.X., Kiberd B.A., Clark W.F., et al. Albuminuria and renal insufficiency prevalence guides population screening: results from the NHANES III. Kidney Int 2002, 61(6):2165-2175.
18. Kramer H.J., Nguyen Q.D., Curhan G., et al. Renal insufficiency in the absence of albuminuria and retinopathy among adults with type 2 diabetes mellitus. JAMA 2003, 289(24):3273-3277.
19. Parving H.H., Lewis J.B., Ravid M., et al. Prevalence and risk factors for microalbuminuria in a referred cohort of type II diabetic patients: a global perspective. Kidney Int 2006, 69(11):2057-2063.
20. Dwyer J.P., Parving H.H., Hunsicker L.G., et al. Renal dysfunction in the presence of normoalbuminuria in type 2 diabetes: results from the DEMAND study. Cardiorenal Med 2012, 2(1):1-10.
21. Caramori M.L., Fioretto P., Mauer M. Low glomerular filtration rate in normoalbuminuric type 1 diabetic patients: an indicator of more advanced glomerular lesions. Diabetes 2003, 52(4):1036-1040.
22. Cirillo M., Laurenzi M., Mancini M., et al. Low glomerular filtration in the population: prevalence, associated disorders, and awareness. Kidney Int 2006, 70(4):800-806.
23. Leitao C.B., Canani L.H., Kramer C.K., et al. Masked hypertension, urinary albumin excretion rate, and echocardiographic parameters in putatively normotensive type 2 diabetic patients. Diabetes Care 2007, 30(5):1255-1260.
24. Packham D.K., Ivory S.E., Reutens A.T., et al. Proteinuria in type 2 diabetic patients with renal impairment: the changing face of diabetic nephropathy. Nephron Clin Pract 2011, 118(4):c331-c338.